Success Stories: With the Help of NAILG, a Pharmaceutical Chemist from India Received His I-140 NIW Along with His EB-1A

Client’s Testimonial:

“While thanking you for all the fruitful efforts from your team, Many thanks for your support in this regard.”

On August 2^nd, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Chemist in the field of Pharmaceutical Sciences (Approval Notice).

General Field: Pharmaceutical Sciences

Position at the Time of Case Filing: Pharmaceutical Chemist

Country of Origin: India

State of Residence at the Time of Filing: New Jersey

Approval Notice Date: August 2^nd, 2021

Processing Time: 16 months, 25 days

Case Summary:

“The United States significantly benefits from [the client’s] studies in this area, as his findings enable the creation of advanced pharmaceuticals that treat thousands of diseases in the country. These public health and economic benefits make the promotion of this industry a national priority. By enhancing the capacity of drug delivery systems, [the client] is supporting the advancement of the pharmaceutical industry and facilitating a nationally valuable sector.”

“Among the many researchers working in this area, one who stands out is [the client]. His findings advance the application of anti-cancer drugs and support the public health of the United States.”

These excerpts are from some of the recommendation letters that our client, a pharmaceutical chemist from India, procured to be used for his petition to USCIS. We at North America Immigration Law Group made sure that all of the documents and relevant information were in place before moving ahead with his NIW (National Interest Waiver) application. Having helped over 25,000 clients in their adjudication process, we were certain that we could lead this case to victory. To assure this outcome, we included the following along with aforesaid letters of support.

His research has resulted in 37 peer-reviewed journal articles (ten of them first-authored). Moreover, these papers have been published in the top journals in his field, reflecting his peers’ recognition of the value of this research. He has published papers in no fewer than four highly ranked peer-reviewed journals.
Due to his knowledge and expertise in the field, our client has been regularly invited to conduct peer reviews for elite journals in the field. Our client has completed at least 5 peer reviews to date.
His publications have been cited a total of 110 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of pharmaceutical sciences. He has thus authored one paper that ranks among the top 1.00% most-cited articles across the entire field for Pharmacology & Toxicology for its respective year of publication. Upon reviewing his citation record, it is clear that he has had a major influence on other scholars’ understanding of topics such as compound synthesis and drug delivery.

With his academic and professional expertise verified, we moved forward to countersign the retainer agreement. We are thankful that he chose our firm to help him with the entire process of adjudication on his I-140 NIW application and also retaining us for his EB-1A petition. We are certain that his work will continue to prove valuable to the United States of America in the future.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.